C

Crinetics Pharmaceuticals

D
CRNX
USD
0.11
(0.1872%)
Market Closed
79,522.00
Volume
-3.66
EPS
-
Div Yield
-15.656915
P/E
4,711,696,360.70
Market Cap
Today
0.1872%
1 Week
-0.406%
1 Month
10.762%
6 Months
22.697%
12 Months
108.095%
Year To Date
65.644%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
C
CRIS
-0.15
(-3.6855%)
USD
B
BNGO
0.0122
(4.609%)
USD
A
ADPT
-0.085
(-1.431%)
USD
L
LPX
-1.28
(-1.135%)
USD
H
HRTX
-0.065
(-5.098%)
USD
X
XERS
0
(0%)
USD
M
MGNX
-0.32
(-7.8049%)
USD
S
STOK
0.28
(2.0543%)
USD
P
PTCT
-0.56
(-1.2539%)
USD

Title:
Crinetics Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
Do you need help or have a question?
Contact Us